The effects of protein supplements on muscle mass, strength, and aerobic and anaerobic power in healthy adults: a systematic review
For now, retatrutide remains investigational, meaning it is only available through clinical trials and has not yet received regulatory approval
GLP-1 therapy carries a risk of hypoglycemia (low blood sugar), particularly when used with other diabetes medications that lower blood glucose
Glossary CKD c hronic kidney disease CNS central nervous system CVD c ardiovascular disease FDA Food and Drug Administration GLP-1 glucagon-like peptide-1 GLP-1s glucagon-like peptide-1 receptor agonists HF Heart failure MASH metabolic dysfunction-associated steatohepatitis OA osteoarthritis OSA obstructive sleep apnea PAD peripheral arterial disease SC subcutaneous T2DM type 2 diabetes mellitus U.S
Always consult with a healthcare professional before making any decisions related to your health.
There is not a single statistically rigorous human trial demonstrating successful transdermal absorption of a GLP-1 drug
